Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulsed Field Ablation (PFA) System for the Treatment of Paroxysmal Atrial Fibrillation (PAF) by Irreversible Electroporation (IRE)

NCT04524364 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT04524364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04524364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulsed Field Ablation (PFA) System for the Treatment of Paroxysmal Atrial Fibrillation (PAF) by Irreversible Electroporation (IRE)
Lead sponsor
Biosense Webster, Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 23, 2020
Completion date
May 9, 2023
Enrollment
272 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation